ArticleFrontiers in oncology2025
Case Report: A rare case of unilateral renal clear cell carcinoma with synchronous contralateral ureteral metastasis.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Renal cell carcinoma (RCC) rarely metastasizes to the contralateral ureter. Fewer than 10 such cases have been reported, mostly involving clear cell RCC (CCRCC) with associated hydronephrosis and renal insufficiency. The mechanism may involve retrograde tumor cell implantation via the urine. This report presents a rare case of unilateral CCRCC with synchronous contralateral ureteral metastasis and its treatment. Case presentation: A 77-year-old male patient presented with hematuria and right lumbar pain. Computed tomography (CT) imaging revealed a left renal mass and a small right ureteral mass with hydronephrosis and suggested malignancy in both masses. Owing to bilateral involvement and poor general condition, a staged approach was adopted. Laparoscopic partial nephrectomy of the left renal mass yielded clear cell renal cell carcinoma (CCRCC). Subsequent laparoscopic nephroureterectomy for the right ureteral tumor confirmed CCRCC metastasis. The patient recovered well and showed no metastasis at the fourteen-month follow-up. Conclusion: This type of metastasis deserves increased attention. However, there is currently no standardized treatment protocol for this rare condition. Our treatment involved firstly management of the renal tumor, followed by the contralateral ureteral tumor so that optimal safety and minimum oncological progression can be achieved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.